Literature DB >> 26617749

Trefoil factor 1 elevates the malignant phenotype of mucinous ovarian cancer cell through Wnt/β-catenin signaling.

Shan Zhao1, Yumei Ma2, Xianghua Huang3.   

Abstract

Mucinous ovarian cancer accounts for almost 10% of epithelial ovarian cancer, though patients in the early stage have an excellent prognosis, patients with advanced disease have a poor outcome and the molecular mechanism remains unclear. In this study, we retrieved database and found a secretory protein TFF1, which plays a tumor suppressor role in gastric cancer, is highly expressed in mucinous ovarian cancer, not serous or any other kind of ovarian cancer. Furthermore, the highly expressed TFF1 indicates a poor clinical outcome. Further biological function analysis revealed that TFF1 not only promotes cell proliferation but also invasion and chemoresistance, and these oncogenic effects might through regulating the activity of Wnt/β-catenin signaling and the level of Twist. Taken together, we found TFF1 plays an oncogenic role in mucinous ovarian cancer, unlike its suppressive role in gastric cancer.

Entities:  

Keywords:  Trefoil Factor 1; Wnt/β-catenin signaling; cell invasion; cell proliferation; chemoresistance; mucinous ovarian cancer

Mesh:

Substances:

Year:  2015        PMID: 26617749      PMCID: PMC4637564     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  17 in total

1.  Complete primary structure of the human estrogen-responsive gene (pS2) product.

Authors:  K Mori; R Fujii; N Kida; H Takahashi; S Ohkubo; M Fujino; M Ohta; K Hayashi
Journal:  J Biochem       Date:  1990-01       Impact factor: 3.387

2.  pS2 (TFF1) levels in human breast cancer tumor samples: correlation with clinical and histological prognostic markers.

Authors:  B E Gillesby; T R Zacharewski
Journal:  Breast Cancer Res Treat       Date:  1999-08       Impact factor: 4.872

3.  Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers.

Authors:  Robertson Mackenzie; Aline Talhouk; Sima Eshragh; Sherman Lau; Daphne Cheung; Christine Chow; Nhu Le; Linda S Cook; Nafisa Wilkinson; Jacqueline McDermott; Naveena Singh; Friedrich Kommoss; Jacobus Pfisterer; David G Huntsman; Martin Köbel; Stefan Kommoss; C Blake Gilks; Michael S Anglesio
Journal:  Am J Surg Pathol       Date:  2015-11       Impact factor: 6.394

4.  miR218-5p regulates the proliferation of gastric cancer cells by targeting TFF1 in an Erk1/2-dependent manner.

Authors:  Ying Shi; Guo-Bin Chen; Qing-Wen Huang; Xu Chen; Jing-Jing Liu; Wei Xu; Xiao-Xiao Huang; Yun-Peng Liu; Chuan-Xing Xiao; Deng-Chyang Wu; Bayasi Guleng; Jian-Lin Ren
Journal:  Biochim Biophys Acta       Date:  2015-01-31

Review 5.  Ovarian cancer: strategies for overcoming resistance to chemotherapy.

Authors:  Roshan Agarwal; Stan B Kaye
Journal:  Nat Rev Cancer       Date:  2003-07       Impact factor: 60.716

6.  Chronological expression of Wnt target genes Ccnd1, Myc, Cdkn1a, Tfrc, Plf1 and Ramp3.

Authors:  Sonja Röhrs; Nadine Kutzner; Annica Vlad; Thomas Grunwald; Slava Ziegler; Oliver Müller
Journal:  Cell Biol Int       Date:  2009-04       Impact factor: 3.612

Review 7.  Genetic alterations in ovarian carcinoma: with specific reference to histological subtypes.

Authors:  Masami Fujita; Takayuki Enomoto; Yuji Murata
Journal:  Mol Cell Endocrinol       Date:  2003-04-28       Impact factor: 4.102

8.  Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.

Authors:  Jing Yang; Sendurai A Mani; Joana Liu Donaher; Sridhar Ramaswamy; Raphael A Itzykson; Christophe Come; Pierre Savagner; Inna Gitelman; Andrea Richardson; Robert A Weinberg
Journal:  Cell       Date:  2004-06-25       Impact factor: 41.582

9.  Rapid loss of intestinal crypts upon conditional deletion of the Wnt/Tcf-4 target gene c-Myc.

Authors:  Vanesa Muncan; Owen J Sansom; Leon Tertoolen; Toby J Phesse; Harry Begthel; Elena Sancho; Alicia M Cole; Alex Gregorieff; Ignacio Moreno de Alboran; Hans Clevers; Alan R Clarke
Journal:  Mol Cell Biol       Date:  2006-09-05       Impact factor: 4.272

10.  Loss of TFF1 promotes Helicobacter pylori-induced β-catenin activation and gastric tumorigenesis.

Authors:  Mohammed Soutto; Judith Romero-Gallo; Uma Krishna; M Blanca Piazuelo; M Kay Washington; Abbes Belkhiri; Richard M Peek; Wael El-Rifai
Journal:  Oncotarget       Date:  2015-07-20
View more
  7 in total

1.  Candidate genes responsible for early key events of phenobarbital-promoted mouse hepatocellular tumorigenesis based on differentiation of regulating genes between wild type mice and humanized chimeric mice.

Authors:  Ayako Ohara; Yasuhiko Takahashi; Miwa Kondo; Yu Okuda; Shuji Takeda; Masahiko Kushida; Kentaro Kobayashi; Kayo Sumida; Tomoya Yamada
Journal:  Toxicol Res (Camb)       Date:  2017-08-24       Impact factor: 3.524

2.  Potential signaling pathways as therapeutic targets for overcoming chemoresistance in mucinous ovarian cancer.

Authors:  Emiko Niiro; Sachiko Morioka; Kana Iwai; Yuki Yamada; Kenji Ogawa; Naoki Kawahara; Hiroshi Kobayashi
Journal:  Biomed Rep       Date:  2018-01-17

Review 3.  Multifunctional DDX3: dual roles in various cancer development and its related signaling pathways.

Authors:  Luqing Zhao; Yitao Mao; Jianhua Zhou; Yuelong Zhao; Ya Cao; Xiang Chen
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

4.  MicroRNA-200 family governs ovarian inclusion cyst formation and mode of ovarian cancer spread.

Authors:  Pui-Wah Choi; Wai Wing So; Junzheng Yang; Shubai Liu; Ka Kui Tong; Kin Ming Kwan; Jamie S-L Kwok; Stephen K W Tsui; Shu-Kay Ng; Karen H Hales; Dale B Hales; William R Welch; Christopher P Crum; Wing-Ping Fong; Ross S Berkowitz; Shu-Wing Ng
Journal:  Oncogene       Date:  2020-03-25       Impact factor: 9.867

5.  TFF3 and TFF1 expression levels are elevated in colorectal cancer and promote the malignant behavior of colon cancer by activating the EMT process.

Authors:  Aikeremu Yusufu; Paerhati Shayimu; Rousidan Tuerdi; Cheng Fang; Fei Wang; Haijiang Wang
Journal:  Int J Oncol       Date:  2019-08-05       Impact factor: 5.650

6.  TFF-1 Functions to Suppress Multiple Phenotypes Associated with Lung Cancer Progression.

Authors:  Kentaro Minegishi; Yoh Dobashi; Hiroyoshi Tsubochi; Koichi Hagiwara; Yuko Ishibashi; Sachiyo Nomura; Ritsuko Nakamura; Yasukazu Ohmoto; Shunsuke Endo
Journal:  Onco Targets Ther       Date:  2021-09-10       Impact factor: 4.147

7.  TFF1 Promotes EMT-Like Changes through an Auto-Induction Mechanism.

Authors:  Elena Romano; Megi Vllahu; Valentina Bizzarro; Raffaella Belvedere; Roberta Esposito; Antonello Petrella; Alessandra Tosco
Journal:  Int J Mol Sci       Date:  2018-07-11       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.